Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Myeloma highlights from EHA 2019
Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain
Myeloma highlights from EHA 2019 ( Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain )
15 Jun 2019
AlloHCT conditioning intensity in AML in complete remission with residual diseas...
Dr Christopher Hourigan - National Heart, Lung, and Blood Institute, Bethesda, U...
AlloHCT conditioning intensity in AML in complete remission with residual disease ( Dr Christopher Hourigan - National Heart, Lung, and Blood Institute, Bethesda, USA )
15 Jun 2019
D-VTd in induction prior to and consolidation after ASCT improves PFS and depth ...
Prof Philippe Moreau - Chu Nantes, Nantes, France
D-VTd in induction prior to and consolidation after ASCT improves PFS and depth of response with acceptable safety ( Prof Philippe Moreau - Chu Nantes, Nantes, France )
14 Jun 2019
Intervention for AML patients with MRD can result in improved survival
Dr Christopher Hourigan - Laboratory of Myeloid Malignancies, National Heart, Lu...
Intervention for AML patients with MRD can result in improved survival ( Dr Christopher Hourigan - Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, NIH, Bethesda, USA )
14 Jun 2019
Novel adoptive cell therapies for acute lymphoblastic leukaemia
Prof Rupert Handgretinger, Director and Chair, Children’s University Hospital an...
Novel adoptive cell therapies for acute lymphoblastic leukaemia ( Prof Rupert Handgretinger, Director and Chair, Children’s University Hospital and Department of Haematology/Oncology, Tübingen, Germany )
24 May 2019
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse
Prof David Marks - University Hospital Bristol, Bristol, UK
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse ( Prof David Marks - University Hospital Bristol, Bristol, UK )
24 May 2019
Optimal use of tyrosine kinase inhibitors as a treatment for Philadelphia chromo...
Prof Hervé Dombret, University Paris Diderot, Paris, France
Optimal use of tyrosine kinase inhibitors as a treatment for Philadelphia chromosome-positive acute lymphoblastic leukaemia ( Prof Hervé Dombret, University Paris Diderot, Paris, France )
24 May 2019
Advanced HCC: New systemic treatment options
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Advanced HCC: New systemic treatment options ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019
The WIN symposium 2019
Prof Razelle Kurzrock - University of California San Diego, San Diego, USA
The WIN symposium 2019 ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )
25 Apr 2019
An overview of the WIN consortium
Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncolo...
An overview of the WIN consortium ( Dr Richard Schilsky - Chief Medical Officer, American Society of Clinical Oncology, USA )
25 Apr 2019
Making oncology global with the WIN consortium
Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Making oncology global with the WIN consortium ( Dr Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
25 Apr 2019
The translational element of the WIN consortium
Dr Brian Leyland-Jones - WIN Head of Fundraising Committee
The translational element of the WIN consortium ( Dr Brian Leyland-Jones - WIN Head of Fundraising Committee )
25 Apr 2019